MISSISSAUGA, ON, Sept. 5, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company"), is announcing its intention to commence a substantial issuer bid (the "Offer" or "SIB") pursuant to which the Company will offer to purchase for cancellation up to $6,000,000 of its outstanding common shares (the "CommonShares"). The Offer commences on September 6, 2023 and will expire on October 11, 2023, unless extended, varied or withdrawn.
Read more at newswire.caCipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
